Cumberland Pharmaceuticals (CPIX) Property, Plant & Equipment (Net) (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) Property, Plant & Equipment (Net) (2010 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 2.55 Bn |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | 3.93 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 3.76 Bn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 13.44 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | 1.93 Bn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 2.44 Bn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | 90.50 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 1.41 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 2.96 Bn |
| 10 | Cumberland Pharmaceuticals | 116.71 Mn | 112.84 Mn | - | 248,808.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 248,808.00 |
| Jun 30, 2026 | 248,808.00 |
| Mar 31, 2026 | 237,375.00 |
| Mar 31, 2026 | 237,375.00 |
| Dec 31, 2025 | 264,724.00 |
| Dec 31, 2025 | 264,724.00 |
| Sep 30, 2025 | 293,375.00 |
| Sep 30, 2025 | 293,375.00 |
| Jun 30, 2025 | 297,793.00 |
| Jun 30, 2025 | 297,793.00 |
| Mar 31, 2025 | 298,740.00 |
| Mar 31, 2025 | 298,740.00 |
| Dec 31, 2024 | 277,365.00 |
| Dec 31, 2024 | 277,365.00 |
| Sep 30, 2024 | 312,031.00 |
| Sep 30, 2024 | 312,031.00 |
| Jun 30, 2024 | 337,089.00 |
| Jun 30, 2024 | 337,089.00 |
| Mar 31, 2024 | 369,499.00 |
| Mar 31, 2024 | 369,499.00 |